| Regine Padilla, PHARM D | |
|
500 W Hospital Rd, French Camp, CA 95231-9693 | |
| (209) 468-6600 | |
| (209) 468-7042 |
| Full Name | Regine Padilla |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 500 W Hospital Rd, French Camp, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538717889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 78950 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Regine Padilla, PHARM D Po Box 1020, Stockton, CA 95201-3120 Ph: () - | Regine Padilla, PHARM D 500 W Hospital Rd, French Camp, CA 95231-9693 Ph: (209) 468-6600 |
News Archive
HUYA Bioscience International, a company at the forefront of globalizing China's biopharmaceutical innovations, today announced a strategic partnership with the School of Pharmaceutical Sciences at Sun Yat-sen University (SYSU). The collaborative agreement expands HUYA's foothold in Southern China, aiming to accelerate the development of novel drugs arising from the school's research efforts.
Third-generation tyrosine kinase inhibitor study findings suggest that bosutinib is associated with a low risk of vascular and cardiac events in patients undergoing first-line or subsequent treatment for chronic myeloid leukaemia.
Heptares Therapeutics, the clinical-stage GPCR structure-guided drug discovery and development company and wholly-owned subsidiary of Sosei Group Corporation, is pleased to announce that it has entered into a licensing agreement with AstraZeneca under which AstraZeneca will acquire exclusive global rights to develop, manufacture and commercialise the adenosine A2A receptor antagonist, HTL-1071, a small molecule immuno-oncology candidate, and potential additional A2A receptor-blocking compounds.
WHO and the Institute of Health Metrics and Evaluation today signed a Memorandum of Understanding defining areas where they will work together to improve the quality and use of global health estimates to measure the world's health challenges.
› Verified 3 days ago
Richard Pigao, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6000 Fax: 209-468-7042 | |
Quynh Tu Pham, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W. Hospital Rd., French Camp, CA 95231 Phone: 209-468-6000 Fax: 209-468-7042 | |
Susan C. Lee, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 West Hospital Rd, French Camp, CA 95231 Phone: 209-468-6937 Fax: 209-468-7042 | |
Jered Michael Arquiette, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W. Hospital Rd., French Camp, CA 95231 Phone: 209-468-6000 Fax: 209-468-7042 | |
Dr. Wilson C Leung, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 209-468-6026 | |
Dr. Allen Shek, PHARM.D., BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 West Hospital Rd, San Joaquin General Hospital, Outpatient Pharmacy, French Camp, CA 95231 Phone: 209-482-2670 Fax: 209-461-2409 | |
Sharon J Bae, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Hospital Rd, French Camp, CA 95231 Phone: 626-808-5085 |